| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/11/1992 | CA1306212C Insulin analogues and process for their preparation |
| 08/11/1992 | CA1306211C Pichia pastoris alcohol oxidase ii regulatory region |
| 08/11/1992 | CA1306210C Bacillus thuringiensis gene encoding a coleopteran-active toxin |
| 08/11/1992 | CA1306209C Fused antigen polypeptide |
| 08/11/1992 | CA1306208C Enhanced expression and stabilization of gene products in microorganisms using short selected leader signal sequences |
| 08/11/1992 | CA1306207C Polypeptide and protein products, and process for their production and use |
| 08/10/1992 | CA2060874A1 Suppressor trna gene transcription systems |
| 08/09/1992 | WO1992013946A1 Htlv-i and htlv-ii peptide antigens and methods |
| 08/09/1992 | CA2060864A1 Non-a, non-b hepatitis related nucleic acids, agents antibodies and their detection reagents |
| 08/07/1992 | CA2060626A1 Chimeric antiidiotypic monoclonal antibodies |
| 08/06/1992 | WO1992013103A1 Inherited and somatic mutations of apc gene in colorectal cancer of humans |
| 08/06/1992 | WO1992013100A1 Analysis of dna |
| 08/06/1992 | WO1992013096A1 Antihuman stromelysin monoclonal antibody and diagnosis of rheumatoid arthritis by enzyme immunoassay |
| 08/06/1992 | WO1992013093A1 Antigen recognized by patients with antibody associated cerebellar degeneration, dna encoding same and uses thereof |
| 08/06/1992 | WO1992013092A1 Methods of transcriptionally modulating expression of hematopoietic growth factor genes |
| 08/06/1992 | WO1992013091A1 Methods of transcriptionally modulating expression of oncogenes and tumor suppressor genes |
| 08/06/1992 | WO1992013090A1 Trans-splicing ribozymes |
| 08/06/1992 | WO1992013089A1 Cell ablation using trans-splicing ribozymes |
| 08/06/1992 | WO1992013082A1 Chilling resistant plants and their production |
| 08/06/1992 | WO1992013081A1 Antigen-presenting capsid with fusion ms2-coat protein |
| 08/06/1992 | WO1992013078A2 Pasteurella haemolytica glycoprotease gene and the purified enzyme |
| 08/06/1992 | WO1992013077A1 A cDNA ENCODING THE TYPE I IODOTHYRONINE 5' DEIODINASE |
| 08/06/1992 | WO1992013076A1 Methods and compositions for the expression of biologically active eukaryotic cytochrome p450s in bacteria |
| 08/06/1992 | WO1992013075A1 Megakaryocyte stimulating factors |
| 08/06/1992 | WO1992013074A1 CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN (CRF-bp) |
| 08/06/1992 | WO1992013073A1 Pdgf-b analogues |
| 08/06/1992 | WO1992013072A2 Process for the synthesis and purification of human ciliary neuronotrophic factor (cntf) from escherichia coli |
| 08/06/1992 | WO1992013071A1 Method of exon amplification |
| 08/06/1992 | WO1992013069A1 Test and model for alzheimer's disease |
| 08/06/1992 | WO1992013065A1 A method of producing autoantibodies |
| 08/06/1992 | WO1992013063A1 Methods of transcriptionally modulating expression of growth factor genes and growth factor receptor genes |
| 08/06/1992 | WO1992013062A1 Jetting device for treating cell |
| 08/06/1992 | WO1992013003A1 Macroscopically oriented cell adhesion protein for wound treatment |
| 08/06/1992 | WO1992013001A1 A RECEPTOR TYROSINE KINASE TARGET PROTEIN cDNA CLONING METHOD AND hGRB PROTEINS |
| 08/06/1992 | WO1992013000A1 Novel thyroid antigen |
| 08/06/1992 | WO1992012996A2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 08/06/1992 | WO1992012994A1 Mixed specificity fusion proteins |
| 08/06/1992 | WO1992012992A2 Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods |
| 08/06/1992 | WO1992012725A1 Treatment of neoplastic disease with interleukin-10 |
| 08/06/1992 | WO1992012635A1 Methods of transcriptionally modulating gene expression of viral genes and other genes |
| 08/06/1992 | DE4103289A1 Determn. of lactose repressor over-producing microorganisms - using a phage with a marker gene contg. C-terminal with a lactose operator and promoter which forms an anti-sense RNA of the marker |
| 08/06/1992 | CA2372251A1 Test and model for alzheimer's disease |
| 08/06/1992 | CA2101781A1 Pasteurella haemolytica glycoprotease gene and the purified enzyme |
| 08/06/1992 | CA2101065A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 08/06/1992 | CA2100790A1 Analysis of dna |
| 08/06/1992 | CA2100553A1 Treatment of neoplastic disease with interleukin-10 |
| 08/06/1992 | CA2100068A1 Trans-splicing ribozymes |
| 08/06/1992 | CA2097424A1 Corticotropin releasing factor binding protein (crf-bp) |
| 08/05/1992 | EP0497585A2 Method of immobilizing and crosslinking proteins and other molecules and uses thereof |
| 08/05/1992 | EP0497464A1 Rapid microbial diagnostics by in situ hybridization in aqueous suspension |
| 08/05/1992 | EP0497368A1 CNP analog peptides and their use |
| 08/05/1992 | EP0497366A2 Antimicrobial peptides and their use against plant pathogens |
| 08/05/1992 | EP0497272A1 Strand displacement amplification |
| 08/05/1992 | EP0497103A2 Gene encoding asymmetrically active esterase |
| 08/05/1992 | EP0496993A1 Enzymatic process for preparing 7-aminocephalosporanic acid and derivatives |
| 08/05/1992 | EP0496973A2 Somatotropins with alterations in the alpha-helix 1 region, and combinations with other mutations |
| 08/05/1992 | EP0496875A1 METHODS FOR PRODUCING RNA VIRUSES FROM cDNA |
| 08/05/1992 | EP0496861A1 RECOMBINANT DNA PRODUCTION OF $g(b)-1,3-GLUCANASE |
| 08/05/1992 | EP0496833A1 BIOSYNTHETIC CONSTRUCTS OF TGF-$g(b) |
| 08/05/1992 | EP0496823A1 Identification of methionine n-alpha-acetyltransferase |
| 08/05/1992 | EP0496820A1 ISOLATING OF STRAINS OF $i(SACCHAROMYCES CEREVISIAE) HAVING ALTERED N?$g(a) -ACETYLTRANSFERASE ACTIVITY |
| 08/05/1992 | EP0496818A1 MONOCLONAL ANTIBODY SPECIFIC FOR IgA RECEPTOR |
| 08/05/1992 | EP0496814A1 Novel expression systems utilizing bacteriophage t7 promoters and gene sequences |
| 08/05/1992 | EP0496794A1 Non-infectious hiv-1 particles and uses therefor |
| 08/05/1992 | EP0496777A1 Dna, constructs, cells and plants derived therefrom |
| 08/05/1992 | EP0486619A4 Method of screening for protein inhibitors and activators |
| 08/05/1992 | EP0478696A4 Efficient method for identifiable expression of non-selectable genes |
| 08/05/1992 | EP0437579A4 Enhancement of naphthalene dioxygenase activity during microbial indigo production |
| 08/05/1992 | EP0217919B1 Type-specific papillomavirus dna sequences and peptides |
| 08/05/1992 | EP0185076B1 Hybrid protein |
| 08/05/1992 | CN1063310A Process for preparation of d-alpha-amino acids |
| 08/05/1992 | CN1017722B Process for preparation of strains of bacillus thuringiensis having improved activity against certain lepidopterous pests |
| 08/04/1992 | US5136032 Method for separating phosphopolyol compounds using a separating agent |
| 08/04/1992 | US5136025 Method to purify basic fibroblast growth factor |
| 08/04/1992 | US5136024 Extraction of granulocyte macrophage colony stimulating factor from bacteria |
| 08/04/1992 | US5136023 Genetically engineered; activity of human fibronectin |
| 08/04/1992 | US5135917 Bind to sense DNA strand coding for receptors |
| 08/04/1992 | US5135868 Cultures of yeast of the genus Pichia altered by site selective genomic modification |
| 08/04/1992 | US5135867 Pesticides, ionsecticides |
| 08/04/1992 | US5135862 Method of isolating restriction fragment deletions in vibrio cholerae, products thereof |
| 08/04/1992 | US5135855 Rapid, versatile and simple system for expressing genes in eukaryotic cells |
| 08/04/1992 | US5135854 Methods of regulating protein glycosylation |
| 08/04/1992 | US5135736 Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
| 08/04/1992 | CA1305932C Process for the preparation of human antithrombin iii (atiii), vectors and host cells suitable for this purpose, biologically active atiii obtained in this way and medicaments containing the latter |
| 08/04/1992 | CA1305931C Yeast strains producing cellulolytic enzymes and methods and means for constructing them |
| 08/04/1992 | CA1305930C Sustained high-level production of recombinant human gamma interferon using a bovine papillomavirus vector |
| 08/04/1992 | CA1305929C Monoclonal antibodies and method for detecting dioxins and dibenzofurans |
| 08/04/1992 | CA1305928C Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes |
| 08/04/1992 | CA1305912C Detection of lymphocyte amplification |
| 08/02/1992 | WO1992013876A1 METHOD OF PRODUCING F(ab')2 FRAGMENTS OF IMMUNOGLOBULINS |
| 08/02/1992 | CA2101337A1 Method of producing f(ab')2 fragments of immunoglobulins |
| 08/01/1992 | WO1992013954A1 BACILLUS THURINGIENSIS CRYIIIC(b) TOXIN GENE AND PROTEIN TOXIC TO COLEOPTERAN INSECTS |
| 08/01/1992 | CA2101338A1 Bacillus thuringiensis cryiiic(b) toxin gene and protein toxic to coleopteran insects |
| 08/01/1992 | CA2058567A1 Exonuclease mediated strand displacement amplification |
| 07/31/1992 | CA2060235A1 Method of immobilizing and crosslinking proteins and other molecules and uses thereof |
| 07/30/1992 | WO1992013079A1 Human protein c expression vector |
| 07/30/1992 | DE4102594A1 Method of expression of genes under nitrogen deficiency - pref. using the glutamine synthetase promoter 2 of E.coli and ammonium and/or glutamine as limiting nitrogen source |
| 07/30/1992 | CA2078667A1 Human protein c expression vector |
| 07/29/1992 | WO1992012728A1 Repressors of the trans-activating function of papillomavirus e2 proteins |
| 07/29/1992 | EP0496606A1 Vav proto-oncogene protein |